Last reviewed · How we verify
A Pharmacodynamic Study of SLM0807, HKB0701 and CJ30001 in Healthy Subject
This trial is conducted to 1. assess whether SLM0807 alters pharmacodynamics of HKB0701 2. estimate the pharmacodynamics of HKB0701 after multiple administration of CJ30001 and multiple co-administration of HKB0701/SLM0807 in healthy subject
Details
| Lead sponsor | HK inno.N Corporation |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 30 |
| Start date | 2010-01 |
| Completion | 2010-03 |
Conditions
- Diabetes Mellitus
Interventions
- Period I : HKB0701, Period II : HKB0701 and SLM0807, Period III : CJ30001
- Period I : HKB0701 and SLM0807, Period II : CJ30001, Period III : HKB0701
- Period I : CJ30001, Period II : HKB0701, Period III : HKB0701 and SLM0807
Primary outcomes
- AUC0-2h of plasma glucose — up to 2hrs
- △Cmax of plasma glucose — up to 2hrs